Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Science Advances|March 4, 2026
Compressive stress-driven Piezo1 activation and Rho-ROCK mechanotransduction promote tumor progression via epigenetic mechanical memorySarah T Boyle, David Gallego-Ortega, Edward J Buckley, et al.
Genesis (New York, N.Y. : 2000)|October 25, 2016
Tissue-selective expression of a conditionally-active ROCK2-estrogen receptor fusion proteinMichael S Samuel, Nicola Rath, Siti F Masre, et al.
Frontiers in Oncology|January 8, 2024
Desmoglein-2 as a cancer modulator: friend or foe?Kay K Myo Min, Charlie B Ffrench, Barbara J McClure, et al.
The Journal of Investigative Dermatology|April 6, 2024
Accelerated Closure of Diabetic Wounds by Efficient Recruitment of Fibroblasts upon Inhibiting a 14-3-3/ROCK Regulatory AxisM Zahied Johan, Natasha T Pyne, Natasha Kolesnikoff, et al.
Carcinogenesis|July 11, 2006
DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinomaStéphanie Boireau, Michael Buchert, Michael S Samuel, et al.
The Journal of Clinical Investigation|August 28, 2012
Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesisThomas Jamieson, Mairi Clarke, Colin W Steele, et al.
Cell Research|November 17, 2010
p53-mediated transcriptional regulation and activation of the actin cytoskeleton regulatory RhoC to LIMK2 signaling pathway promotes cell survivalDaniel R Croft, Diane Crighton, Michael S Samuel, et al.
Oncotarget|October 27, 2015
Cytoskeletal protein Flightless I inhibits apoptosis, enhances tumor cell invasion and promotes cutaneous squamous cell carcinoma progressionZlatko Kopecki, Gink N Yang, Jessica E Jackson, et al.
British Journal of Cancer|April 30, 2021
A deep convolutional neural network for segmentation of whole-slide pathology images identifies novel tumour cell-perivascular niche interactions that are associated with poor survival in glioblastomaAmin Zadeh Shirazi, Mark D McDonnell, Eric Fornaciari, et al.
British Journal of Haematology|December 6, 2023
An orthotopic syngeneic mouse model of bortezomib-resistant multiple myelomaManjun Li, Melissa K Bennett, John Toubia, et al.
Pageof 5